tyramine-deoxysorbitol: Clinical Trials

9 trials of tyramine-deoxysorbitol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 4 Phase 3, 2 Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Not yet recruiting 1, Unknown 1
Phase 12Completed 2
Not applicable1Completed 1
Phase 21Completed 1
Phase 41Withdrawn 1

Follow tyramine-deoxysorbitol: new trials by email Literature Review of tyramine-deoxysorbitol trials Research Report on tyramine-deoxysorbitol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess
Diloxanide furoate, Placebo - Liver Abscess, Amoebic Liver Abscess
Phase 3Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh2202026-09-042026-09-10
Berberine and Cinnamon in Management of Diabetes
Berberine+Cinnamon (TDS), Placebo (TDS) - Diabetes
Not applicableCompletedNational Nutrition and Food Technology Institute442022-07-012024-06-11
Combination HTNV and PUUV DNA Vaccine
Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intradermal Delivery (ID), Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intramuscular Delivery (IM), Puumala virus vaccine (PUUV) - Using the TriGrid Delivery System (TDS) for Intradermal Delivery (ID) - Hantaan Virus Disease, Puumala Virus
Phase 1CompletedU.S. Army Medical Research and Development Command612019-07-102025-06-26
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
Scopolamine Transdermal Patch [Transderm Scop], Scopolamine, Placebo Patch - Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness
Phase 3UnknownNaval Aeromedical Research Unit, Dayton3202019-04-012019-04-19
Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion
SUN-131 1.5% TDS, Placebo TDS - Chalazion
Phase 3CompletedSenju USA, Inc.2632017-07-312021-08-05
A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants
Duragesic (Fentanyl Transdermal System [TDS] Small Patches), New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches), Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches) - Healthy
Phase 1CompletedJanssen Research & Development, LLC522015-11-172025-02-03
Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
SUN-131 1.5% TDS, Placebo TDS - Chalazion
Phase 2CompletedSenju USA, Inc.602014-10-012017-08-11
Etoricoxib in Acute Ankle Ligament Sprains
Ankle brace, Diclofenac 50 mg tds, Etoricoxib 120 mg mane - Sprain
Phase 4WithdrawnUniversity of Cape Town2009-11-012013-06-20
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
Buprenorphine transdermal patch, Placebo oxycodone/acetaminophen tablets, OXY/APAP - Back Pain
Phase 3CompletedPurdue Pharma LP1341997-12-012012-09-03

Conditions studied

Chalazion (2)  ·  Back Pain (1)  ·  Diabetes Mellitus (1)  ·  Hantavirus Infections (1)  ·  Liver Abscess (1)  ·  Liver Abscess, Amebic (1)  ·  Motion Sickness (1)  ·  Sprains and Strains (1)

Sponsors

Senju USA, Inc. (2)  ·  Janssen Research & Development, LLC (1)  ·  National Nutrition and Food Technology Institute (1)  ·  Naval Aeromedical Research Unit, Dayton (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Purdue Pharma LP (1)  ·  U.S. Army Medical Research and Development Command (1)  ·  University of Cape Town (1)

Countries

United States (6)  ·  India (1)  ·  Iran (1)  ·  South Africa (1)

Top investigators

Kirsten E Lyke, MD (1)  ·  Martin P Schwellnus, MBBCh, MD (1)

Results publications

PMID 11861988, PMID 15029042, PMID 15878075, PMID 21257145, PMID 32797734